Literature DB >> 21898138

Patterns of dietary and herbal supplement use by multiple sclerosis patients.

Kerri O'Connor1, Bianca Weinstock-Guttman, Ellen Carl, Colleen Kilanowski, Robert Zivadinov, Murali Ramanathan.   

Abstract

To assess the patterns of dietary (DS) and herbal supplement (HS) use in MS patients, compare use between MS patients and healthy controls and to identify potential interactions with drugs used to treat MS. This study included 279 MS subjects and 161 controls from a study of risk factors in MS. All patients received a neurological examination. All subjects provided responses to a standardized questionnaire administered during an in-person interview. A larger proportion of MS patients (82.1%) compared to controls (60.1%) used one or more DS regularly for at least 3 months (p < 0.001). There was a trend toward a higher proportion of MS patients (26.6%) versus controls (17.8%) who used HSs for more than 1 month (p = 0.038). The most common DS used after MS onset was a multivitamin (78.1%), followed by vitamin D (65.8%). Use of the majority of specific DSs increased significantly after MS onset compared to before. The proportion of controls and MS patients after MS onset who reported using an individual HS was generally similar. The most commonly used HS in patients after MS was evening primrose oil (40.4%) followed by cranberry fruit extract (35.2%). There was no evidence for associations with progressive disease course or with choice of disease-modifying treatment. Dietary supplements are used more frequently by MS patients than controls. Use tends to increase after MS onset compared to before, especially for DS. The use of HS by MS patients is only modestly greater than by controls.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21898138     DOI: 10.1007/s00415-011-6226-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

Review 1.  Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals.

Authors:  Nicole C Brazier; Mitchell A H Levine
Journal:  Am J Ther       Date:  2003 May-Jun       Impact factor: 2.688

2.  Complementary and alternative medicine for the treatment of multiple sclerosis.

Authors:  Vijayshree Yadav; Lynne Shinto; Dennis Bourdette
Journal:  Expert Rev Clin Immunol       Date:  2010-05       Impact factor: 4.473

3.  Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why?

Authors:  E M Leong; S J Semple; M Angley; W Siebert; J Petkov; R A McKinnon
Journal:  Complement Ther Med       Date:  2009-04-21       Impact factor: 2.446

4.  Use of unconventional therapies by individuals with multiple sclerosis.

Authors:  Sangeetha Nayak; Robert J Matheis; Nancy E Schoenberger; Samuel C Shiflett
Journal:  Clin Rehabil       Date:  2003-03       Impact factor: 3.477

5.  What do people with MS want and expect from health-care services?

Authors:  M Somerset; R Campbell; D J Sharp; T J Peters
Journal:  Health Expect       Date:  2001-03       Impact factor: 3.377

Review 6.  A review of complementary and alternative medicine (CAM) by people with multiple sclerosis.

Authors:  Sherri A Olsen
Journal:  Occup Ther Int       Date:  2009       Impact factor: 1.448

Review 7.  Identification of drugs that interact with herbs in drug development.

Authors:  Shu-Feng Zhou; Zhi-Wei Zhou; Chun-Guang Li; Xiao Chen; Xiyong Yu; Charlie Changli Xue; Adrian Herington
Journal:  Drug Discov Today       Date:  2007-07-30       Impact factor: 7.851

8.  Unconventional therapy in multiple sclerosis.

Authors:  Jaume Sastre-Garriga; Elvira Munteis; Jordi Río; Imma Pericot; Mar Tintoré; Xavier Montalban
Journal:  Mult Scler       Date:  2003-06       Impact factor: 6.312

9.  Why physicians need to look more closely at the use of complementary and alternative medicine by multiple sclerosis patients.

Authors:  E Pucci; E Cartechini; C Taus; G Giuliani
Journal:  Eur J Neurol       Date:  2004-04       Impact factor: 6.089

10.  Complementary and alternative therapy use in persons with multiple sclerosis.

Authors:  Alexa K Stuifbergen; Tracie Culp Harrison
Journal:  Rehabil Nurs       Date:  2003 Sep-Oct       Impact factor: 1.625

View more
  13 in total

Review 1.  Managing Disability in Progressive Multiple Sclerosis.

Authors:  Divyanshu Dubey; Peter Sguigna; Olaf Stüve
Journal:  Curr Treat Options Neurol       Date:  2016-06       Impact factor: 3.598

2.  Complementary and Alternative Medicine Usage by Multiple Sclerosis Patients: Results from a Prospective Clinical Study.

Authors:  Soohyun Kim; Lawrence Chang; Bianca Weinstock-Guttman; Sirin Gandhi; Dejan Jakimovski; Ellen Carl; Robert Zivadinov; Murali Ramanathan
Journal:  J Altern Complement Med       Date:  2018-03-02       Impact factor: 2.579

3.  Complementary and alternative medicine use and nutrient intake among individuals with multiple sclerosis in the United States.

Authors:  Laura Masullo; Mia A Papas; Nancy Cotugna; Sandra Baker; Lauren Mahoney; Jillian Trabulsi
Journal:  J Community Health       Date:  2015-02

4.  Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy.

Authors:  A Loraschi; P Bellantonio; F Bortolon; R Capra; P Cavalla; G Costantino; A Lugaresi; V Martinelli; M G Marrosu; F Patti; M Rottoli; M Salvetti; P Sola; C Solaro; C Klersy; F Marino; M Zaffaroni; M Cosentino
Journal:  Neurol Sci       Date:  2016-02-19       Impact factor: 3.307

5.  Dietary factors and pediatric multiple sclerosis: A case-control study.

Authors:  Julia Pakpoor; Brandon Seminatore; Jennifer S Graves; Teri Schreiner; Amy T Waldman; Timothy E Lotze; Anita Belman; Benjamin M Greenberg; Bianca Weinstock-Guttman; Gregory Aaen; Jan-Mendelt Tillema; Jamie C McDonald; Janace Hart; Jayne M Ness; Yolanda Harris; Jennifer Rubin; Meghan Candee; Lauren Krupp; Mark Gorman; Leslie Benson; Moses Rodriguez; Tanuja Chitnis; Soe Mar; Ilana Kahn; John Rose; Suzan L Carmichael; Shelly Roalstad; Michael Waltz; T Charles Casper; Emmanuelle Waubant
Journal:  Mult Scler       Date:  2017-06-13       Impact factor: 6.312

6.  Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders.

Authors:  J Hagemeier; M Heininen-Brown; T Gabelic; T Guttuso; N Silvestri; D Lichter; L E Fugoso; N Bergsland; E Carl; J J G Geurts; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-29       Impact factor: 3.825

7.  Reserve-building activities in multiple sclerosis patients and healthy controls: a descriptive study.

Authors:  Carolyn E Schwartz; Armon Ayandeh; Murali Ramanathan; Ralph Benedict; Michael G Dwyer; Bianca Weinstock-Guttman; Robert Zivadinov
Journal:  BMC Neurol       Date:  2015-08-12       Impact factor: 2.474

8.  Dietary interventions for multiple sclerosis-related outcomes.

Authors:  Natalie E Parks; Caitlin S Jackson-Tarlton; Laura Vacchi; Roah Merdad; Bradley C Johnston
Journal:  Cochrane Database Syst Rev       Date:  2020-05-19

9.  Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients.

Authors:  Elliot Graziano; Jesper Hagemeier; Bianca Weinstock-Guttman; Deepa P Ramasamy; Robert Zivadinov
Journal:  Neuroimage Clin       Date:  2015-08-01       Impact factor: 4.881

Review 10.  Iranian consensus on use of vitamin D in patients with multiple sclerosis.

Authors:  Soodeh Razeghi Jahromi; Mohammad Ali Sahraian; Mansoureh Togha; Behnaz Sedighi; Vahid Shayegannejad; Alireza Nickseresht; Shahriar Nafissi; Niayesh Mohebbi; Nastran Majdinasab; Mohsen Foroughipour; Masoud Etemadifar; Nahid Beladi Moghadam; Hormoz Ayramlou; Fereshteh Ashtari; Shekoofe Alaie
Journal:  BMC Neurol       Date:  2016-05-21       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.